INTERNATIONAL PATENT: AAVATAR THERAPEUTICS CO.,LTD., 주식회사 아바타테라퓨틱스 FILES APPLICATION FOR "BEST1 GENE EDITING METHOD USING CRISPR/CAS SYSTEM"

GENEVA, Jan. 13 -- AAVATAR THERAPEUTICS CO.,LTD. ((Deokpung-dong) BA 10-023, 540 Misa-daero,Hanam-si,Gyeonggi-do 12925), 주식회사 아바타테라퓨틱스 (경기도하남시미사대로 540, 제비에이 10-023호 (덕풍동)) filed a patent application (PCT/KR2025/009018) for "BEST1 GENE EDITING METHOD USING CRISPR/CAS SYSTEM" on Jun 26, 2025. With publication no. WO/2026/010243, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the Wor...